XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.2
Common Stock, Stock Options and Warrants (Details) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Nov. 02, 2021
Nov. 01, 2021
Oct. 11, 2021
Jun. 10, 2021
Apr. 30, 2021
Oct. 06, 2020
Jun. 30, 2022
Apr. 30, 2022
Mar. 21, 2022
Feb. 28, 2022
Jan. 31, 2022
May 24, 2021
Feb. 19, 2021
Feb. 16, 2021
Jan. 27, 2021
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 21, 2021
Mar. 31, 2021
Dec. 31, 2020
Nov. 05, 2020
Sep. 30, 2020
Sep. 11, 2020
Feb. 10, 2020
Feb. 07, 2018
Common Stock, Stock Options and Warrants (Details) [Line Items]                                                          
Common shares authorized             400,000,000                   400,000,000       400,000,000                
Common stock offerings, description                             the Company closed a private placement for 15,455,960 common shares and warrants to purchase 7,727,980 common shares, at a purchase price of $1.294 per common share and accompanying warrant, for gross proceeds of $20,000,012. The 7,727,980 warrants are immediately exercisable at $1.231 per common share for a term of five and one-half years. The Company paid the placement agent a fee of 7% of the gross proceeds totaling $1,400,001 and issued the placement agent 1,081,917 immediately exercisable warrants at $1.6175 per common share for a term of five and one-half years. The Company also reimbursed the placement agent for $85,000 in expenses and incurred $64,601 in other expenses. Net proceeds from the offering were $18,450,410. The estimated fair value of the 7,727,980 warrants issued to the investors was approximately $7,582,000 and the estimated fair value of the 1,081,917 warrants issued to the placement agent was approximately $1,025,000.                            
Issued shares                 100,000                                        
Fair value of common stock (in Dollars)                 $ 178,000                                        
Common shares reserved                                                 2,000,000        
Option to purchase share outstanding             4,855,000                   4,855,000                        
Remaining shares                                                     7,500,000    
Shares available for future grants                                 3,885,000                        
Options to purchase shares   200,000 175,000     125,000 80,000 80,000   300,000 300,000                                    
Share price (in Dollars per share)   $ 1.87 $ 2.04     $ 1.01 $ 1.67                   $ 1.67                        
Exercise price (in Dollars per share)         $ 1.42                                                
Options vest over terms                                 10 years                        
Share issued price per share                                   1.03                      
Stock-based compensation expense description                                 Stock-based compensation expense for the three months ended June 30, 2022 and 2021 was $1,003,677 (including $33,333 for the NoveCite Stock Plan) and $373,570 (including $18,833 for the NoveCite Stock Plan), respectively. Stock-based compensation expense for the nine months ended June 30, 2022 and 2021 was $2,929,279 (including $99,999 for the NoveCite Stock Plan) and $993,114 (including $50,222 for the NoveCite Stock Plan), respectively.                         
Citius stock plans (in Dollars)             $ 6,261,023                   $ 6,261,023                        
Weighted average period term                                 2 years 1 month 6 days                        
Common shares outstanding                                 2,000,000                        
Stock option plan description                                 NoveCite has options outstanding to purchase 2,000,000 common shares at a weighted average exercise price of $0.24 per share, of which 376,665 are exercisable. All of these options vest over 36 months and have a term of 10 years. The weighted average remaining contractual term of options outstanding under the NoveCite Stock Plan is 8.7 years. At June 30, 2022, unrecognized total compensation cost related to unvested awards under the NoveCite Stock Plan of $216,444 is expected to be recognized over a weighted average period of 1.7 years.                        
Warrants extended term         3 years                                                
Warrants for common stock (in Dollars)         $ 1,294,498                                                
Deemed dividend (in Dollars)                               $ 1,450,876 $ 1,450,876                        
Common Stock [Member]                                                          
Common Stock, Stock Options and Warrants (Details) [Line Items]                                                          
Issued shares 50,201                                                        
Fair value of common stock (in Dollars) $ 95,884                                                        
Shares outstanding             146,129,630                 145,979,429 146,129,630 145,979,429 146,129,630 146,029,630 145,979,429   134,701,219 55,576,996   55,576,996      
Options to purchase shares     375,000     175,000                                              
Warrants [Member]                                                          
Common Stock, Stock Options and Warrants (Details) [Line Items]                                                          
Exercise price (in Dollars per share)         $ 1.93                                                
Warrants for common stock (in Dollars)         $ 240,130                                                
Weighted average remaining life of the outstanding warrants             3 years                   3 years                        
Aggregate intrinsic value for the warrants outstanding (in Dollars)                                 $ 418,995                        
Minimum [Member]                                                          
Common Stock, Stock Options and Warrants (Details) [Line Items]                                                          
Shares of capital stock authorized                                           210,000,000              
Common shares authorized                                           200,000,000              
Exercise price (in Dollars per share)             $ 0.9 $ 0.9   $ 1.44 $ 1.44           $ 0.9                        
Maximum [Member]                                                          
Common Stock, Stock Options and Warrants (Details) [Line Items]                                                          
Shares of capital stock authorized                                           410,000,000              
Common shares authorized                                           400,000,000              
Exercise price (in Dollars per share)             $ 1.47 $ 1.47   $ 1.49 $ 1.49           $ 1.47                        
Board of Directors [Member]                                                          
Common Stock, Stock Options and Warrants (Details) [Line Items]                                                          
Options to purchase shares     2,515,000     800,000               125,000                              
Share price (in Dollars per share)                           $ 1.69                              
Options vest over terms                                 10 years                        
Granted stock options to purchase       100,000                                                  
Employees shares       10,000                                                  
Consultant shares (in Dollars per share)       $ 2.5                                                  
Registered Direct Offering [Member]                                                          
Common Stock, Stock Options and Warrants (Details) [Line Items]                                                          
Common stock offerings, description                         the Company closed a registered direct offering for 50,830,566 common shares and warrants to purchase up to 25,415,283 common shares, at a purchase price of $1.505 per share of common stock and accompanying warrant, for gross proceeds of $76,500,002. The 25,415,283 warrants are immediately exercisable at $1.70 per common share for a term of five years. The Company paid the placement agent a fee of 7% of the gross proceeds totaling $5,355,000 and issued the placement agent 3,558,140 immediately exercisable warrants at $1.881 per common share for a term of five years. The Company also reimbursed the placement agent for $85,000 in expenses and incurred $80,160 in other expenses. Net proceeds from the offering were $70,979,842. The estimated fair value of the 25,415,283 warrants issued to the investors was approximately $42,322,000 and the estimated fair value of the 3,558,140 warrants issued to the placement agent was approximately $5,850,000.                                
2014 Stock Incentive Plan [Member]                                                          
Common Stock, Stock Options and Warrants (Details) [Line Items]                                                          
Common stock for issuance             866,667                   866,667                        
Shares outstanding             855,171                   855,171                        
2018 Omnibus Stock Incentive Plan [Member]                                                          
Common Stock, Stock Options and Warrants (Details) [Line Items]                                                          
Common stock for issuance                                                         2,000,000
Number of shares outstanding             1,820,000                   1,820,000                        
2020 Stock Plan [Member]                                                          
Common Stock, Stock Options and Warrants (Details) [Line Items]                                                          
Common shares reserved                                                       3,110,000  
2021 Omnibus Stock Incentive Plan [Member]                                                          
Common Stock, Stock Options and Warrants (Details) [Line Items]                                                          
Option to purchase share outstanding             1,870,000                   1,870,000                        
Remaining shares             1,240,000                   1,240,000                        
2021 Stock Plan [Member]                                                          
Common Stock, Stock Options and Warrants (Details) [Line Items]                                                          
Issued shares                       8,740,000                                  
Shares available for future grants                                 3,885,000                        
Stock Options [Member]                                                          
Common Stock, Stock Options and Warrants (Details) [Line Items]                                                          
Contractual term                                 10 years